Article Text

Download PDFPDF
Rotavirus vaccine in South Africa, Malawi and Mexico

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Successive articles in the New England Journal of Medicine (Shabir A Madhi and colleagues. N Engl J Med 2010;362:289–98; Vesta Richardson and colleagues. Ibid:299–305; see also editorial; ibid:358–60) have reported on the efficacy of rotavirus vaccine in South Africa and Malawi and in Mexico.

The African trial of Rotarix, an attenuated human rotavirus vaccine containing a G1P[8] strain included 3166 infants in South Africa and 1773 in Malawi. Randomisation was to three options with administration at ages 6, 10 and 14 weeks: two doses of vaccine and one of placebo, three doses …

View Full Text


  • Provenance and peer review Not commissioned; internally peer reviewed.